Cargando…
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
BACKGROUND: Tobacco smoking is a highly prevalent, addictive behaviour and a key public health priority. However available cessation therapies have low quit and high relapse rates, indicating an urgent need for more effective treatments. Predicated on promising preclinical and pilot clinical data, t...
Autores principales: | Arancini, Lauren, Bortolasci, Chiara C., Dodd, Seetal, Dean, Olivia M., Berk, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734392/ https://www.ncbi.nlm.nih.gov/pubmed/31500670 http://dx.doi.org/10.1186/s13063-019-3628-5 |
Ejemplares similares
-
ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis
por: Cotton, S. M., et al.
Publicado: (2019) -
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial
por: Skvarc, David R., et al.
Publicado: (2016) -
Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR)
por: Druckrey-Fiskaaen, Karl Trygve, et al.
Publicado: (2022) -
Evaluating discussion board engagement in the MoodSwings online self-help program for bipolar disorder: protocol for an observational prospective cohort study
por: Gliddon, Emma, et al.
Publicado: (2015) -
Study protocol of the German Study on Tobacco Use (DEBRA): a national household survey of smoking behaviour and cessation
por: Kastaun, Sabrina, et al.
Publicado: (2017)